NexGen Biobanking
Gabriela Bout Denning is the Director of Scientific Operations at NexGen Biobanking, with a background as Vice President of Research & Development at Expression Therapeutics LLC. She has experience in overseeing research & development projects, managing research staff, implementing regulatory guidelines, and supporting organizational operations. Previously, she has worked as a Post-Doctoral at Emory University and as a Research Associate at The Scripps Research Institute. Gabriela holds a PhD in Biochemistry from The University of Texas Medical Branch and a BS in Molecular Biology from Florida Institute of Technology.
This person is not in any teams
NexGen Biobanking
Customer-centric leader in specimen storage and supply solutions in support of precision medicine and life sciences designed around a commitment to improving research with innovation and knowledge. NexGen Biobanking is a CAP accredited biorepository offering full life-cycle specimen management services supporting academic, pharmaceutical, biotech, and healthcare institutions. We provide expertise in all scientific, technical, and legal aspects of biobanking including specimen collection, processing, and storage; inventory management and dissemination; cold chain management; and equipment and environmental monitoring. Our on-site biorepository services are provided in a custom-designed facility utilizing technologically advanced infrastructure, IT solutions, and specimen storage equipment. Client collections are processed, handled, and stored following global industry Best Practices to ensure the integrity and quality of the biospecimens. Company focus is centered around a commitment to providing timely and responsive service to clients in support of their research goals.